The mother was followed for shortened cervix and preterm labor.
She received betamethasone on [**4-28**] and [**2166-4-29**].
She progressed in labor and became refractory to magnesium sulfate tocolysis.
The infant breathed spontaneously after delivery but had persistent cyanosis.
She received bag mask ventilation for one to two minutes.
She was intubated for inconsistent respiratory effort and persistent cyanosis.
She was admitted to the Neonatal Intensive Care Unit for treatment of prematurity.
Orally, endotracheal tube was placed.
HOSPITAL COURSE:  System 1:  Respiratory:  [**Known lastname **] received two doses of Surfactant after admission to the Neonatal Intensive Care Unit.
Her maximum ventilatory settings were a peak inspiratory pressure of 20, over a positive end expiratory pressure of 5; intermittent mandatory ventilatory rate of 25 and 30 percent oxygen.
She remained on a continuous positive airway pressure through day of life number 10.
She was taken off the continuous positive airway pressure and placed in room air.
The caffeine was discontinued on day of life 47.
Last episode of spontaneous bradycardia occurred with a feeding on [**2166-7-27**].
System 3:  Fluids, electrolytes and nutrition:  [**Known lastname **] was initially npo and maintained on intravenous fluids.
Enteral feedings were started on day of life five and gradually advanced to full volume.
She received total parenteral nutrition through the first twelve days of life.
She gradually weaned off gavage feedings and was all p.o.
She was started on Reglan on [**2166-7-20**] with marked improvement in her spitting and bradycardiac episodes.
At the time of discharge, she is taking approximately 200 cc per kg per day of Enfamil AR formula, fortified to 24 calories per ounce, 4 calories by corn oil.
A blood culture obtained prior to starting intravenous antibiotics was no growth at 72 hours and the antibiotics were discontinued.
The blood culture was no growth at 48 hours and the antibiotics were discontinued.
System 5:  Gastrointestinal:  As previously noted, [**Known lastname **] is being treated for gastroesophageal reflux with Reglan and anti-reflux formula.
She also required treatment for unconjugated hyperbilirubinemia in the first week of life.
She received five days of phototherapy with a rebound bilirubin of 2.5 ml/dl unconjugated.
She is being discharged on supplemental iron.
She did not receive any transfusions of blood products during admission.
Medications:  Reglan 0.3 mg p.o.
Ferrous sulfate 25 mg/ml dilution 0.25 ml p.o.
IMMUNIZATIONS:  Hepatitis B vaccine on [**6-25**] and [**2166-8-1**].
Diptheria, acellular pertussis, injectable polio, pneumococcal 7-valent conjugate vaccine and Hemophilus influenza B were all administered on [**2166-7-5**].
Synagis RSV prophylaxis was administered on [**2166-8-1**].
IMMUNIZATIONS RECOMMENDED:  Synagis RSV prophylaxis should be considered from [**Month (only) 359**] to [**Month (only) 547**] for infants who meet any of the following three criteria:  1. )
Influenza immunization is recommended annually in the Fall for all infants once they reach six months  of age.
Before this age, and for the first 24 months of the child's life, immunization against influenza is recommended for household contacts and out of home caregivers.
Patent ductus arteriosus, status post treatment with Indomethacin.
